Life Insurance for Arthritis

Getting approved for life insurance with arthritis can feel frustrating, especially if you’ve already run into higher rates or confusing underwriting questions. Arthritis is one of those conditions where the label alone doesn’t tell the full story — and insurance companies know that. What underwriters really want to understand is how your diagnosis affects daily function, how stable your symptoms are over time, what medications you rely on, and whether your arthritis has caused complications that increase long-term risk. The good news is that many people with osteoarthritis, rheumatoid arthritis, psoriatic arthritis, or gout can still qualify for strong coverage — often at more competitive rates than they expect — when the file is positioned correctly. At Diversified Insurance Brokers, we help clients with chronic conditions — including every major type of arthritis — secure life insurance through our network of 100+ A-rated carriers. Arthritis underwriting varies significantly between companies. Some carriers treat rheumatoid arthritis as an automatic table rating regardless of how well-controlled it is. Others place substantial weight on stable follow-ups, limited flares, normal inflammatory markers, and strong lifestyle habits. Because our advisors work high-risk and chronic condition cases every week, we know what underwriters want to see, which carriers are the best fit, and how to avoid overpriced quotes that don’t reflect your true risk profile. If you’ve been quoted higher than expected, declined, or told you’ll need guaranteed-issue coverage, that may simply reflect a case that wasn’t presented to the right carrier — not an accurate picture of what you can actually qualify for. For broader context on how chronic conditions interact with underwriting, see our guide to life insurance with pre-existing conditions and our overview of how to get life insurance with health issues.

Can You Get Life Insurance With Arthritis?

Yes — for many applicants, it is far more affordable than they assume. Arthritis is one of the most common conditions carriers underwrite, and most have well-developed guidelines for it. The critical distinction is that “arthritis” is not one condition from an underwriting standpoint. Osteoarthritis is generally viewed as a wear-and-tear mechanical condition and is often underwritten more favorably, especially when mobility is preserved and pain management is stable. Rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis are inflammatory autoimmune conditions — carriers ask deeper questions about systemic involvement, medication intensity, long-term stability, and whether complications such as joint deformity, chronic steroid dependence, or cardiovascular concerns related to systemic inflammation are present. Gout is a metabolic inflammatory arthritis with its own underwriting considerations around uric acid control, attack frequency, and kidney function. One of the biggest mistakes applicants make is assuming arthritis automatically pushes them into guaranteed-issue life insurance. In many cases, a fully underwritten term policy can be approved, particularly when arthritis is well-controlled and the rest of the health profile is clean. Even when the final decision is a table rating, the difference between a Table 2 and a Table 6 can be thousands of dollars over the life of a policy — which is exactly why carrier selection and underwriting presentation matter enormously. See our guide to life insurance table ratings explained for a clear picture of what table ratings mean in real premium terms.

Arthritis Types at a Glance: How Underwriters Differentiate Them

Why Arthritis Underwriting Is Not One Size Fits All

Insurance underwriting for arthritis is less about the diagnosis name and more about what that diagnosis looks like in real life. Underwriters assess patterns, risk consistency, and functional outcomes. Two people could both have rheumatoid arthritis — one with mild flares, stable labs, and normal daily function, and another requiring frequent steroid bursts, multiple medication changes, and limitations affecting work. Those two cases do not price the same, and they should not. The underwriting result depends on details like flare frequency, symptom severity, stability of treatment, and whether there are complications outside the joints. This is also why applicants who apply directly online often get misleading results — automated quote engines cannot see the difference between controlled and uncontrolled disease, and they do not know how each carrier interprets biologics, DMARDs, and long-term steroid use. Our guide to the best high-risk life insurance companies provides context on which carriers are known for more nuanced, fair underwriting on chronic conditions like inflammatory arthritis. For applicants who want a direct overview of how to approach the application process, see our resource on best life insurance for pre-existing conditions.

How Osteoarthritis Affects Life Insurance

Osteoarthritis (OA) is often the easiest type of arthritis to insure because it is considered degenerative rather than autoimmune. Underwriters typically focus on functional limitations, pain management, and any related surgical history — particularly joint replacements. If you’ve had a knee or hip replacement and recovered well, that can actually be a stabilizing factor in underwriting because it demonstrates the issue was addressed and mobility improved. In mild to moderate OA cases, insurers may ask only basic questions and can still offer strong classifications depending on age, build, blood pressure, cholesterol, tobacco status, and other standard metrics. When OA creates significant mobility limitations, it raises concern because reduced mobility can correlate with higher cardiovascular risk and reduced activity over time. That does not make coverage impossible — it means the underwriting file needs to show stability, continued engagement with medical care, and clear documentation of management. If an insurer sees consistent physician follow-up and no major complications, OA remains a manageable underwriting condition for most applicants. For smokers with OA, nicotine use compounds the underwriting impact significantly — see our guide on life insurance for smokers to set realistic expectations for how tobacco affects pricing when combined with a chronic condition.

How Rheumatoid and Psoriatic Arthritis Affect Life Insurance

Rheumatoid arthritis (RA) and psoriatic arthritis involve systemic inflammation and often require immunomodulating medications. Underwriters view inflammatory arthritis through a “long-term severity” lens — they want to understand how aggressive the disease has been historically, whether it has stabilized, and whether the treatment plan is predictable. Many carriers will ask when you were diagnosed, how frequently you have flares, whether you have morning stiffness lasting longer than an hour, whether work duties are limited, and whether repeated steroid use has been required. Inflammatory markers — including ESR, CRP, rheumatoid factor (RF), and anti-CCP antibodies — often come up in underwriting review for RA cases, because they provide objective evidence of disease activity and the effectiveness of current treatment. Consistent follow-up with a rheumatologist showing stable, normal, or trending-downward inflammatory markers supports a much stronger underwriting case than one where markers are elevated or poorly tracked.

Medication is a major underwriting factor in RA and psoriatic arthritis. Someone controlled on NSAIDs or occasional low-dose DMARDs may be viewed as mild. Someone on a biologic like adalimumab (Humira) or etanercept (Enbrel) is often considered moderate to severe — but stable biologic therapy can sometimes strengthen a case because it suggests a consistent long-term management plan rather than uncontrolled progression. The cardiovascular dimension of RA is also important to understand: people with RA face a meaningfully elevated risk of cardiovascular disease compared to the general population, and many underwriters account for this when pricing RA cases. If there is any cardiovascular history alongside RA — high blood pressure, atrial fibrillation, or prior cardiac events — each of those factors compounds the underwriting picture. See our resources on life insurance with heart disease, life insurance with high blood pressure, and life insurance with atrial fibrillation for how these specific complications are evaluated individually — and understand that when they appear alongside inflammatory arthritis, the combined profile requires careful carrier selection and case positioning. Because RA is an autoimmune condition, underwriters may also reference how the carrier handles other autoimmune histories — our guide to life insurance for autoimmune disease and our resource on life insurance with lupus (another autoimmune inflammatory disease with joint involvement) provide useful comparison context.

Gout: The Metabolic Arthritis That Has Its Own Underwriting Track

Gout is caused by uric acid crystal deposition in joints — a metabolic process rather than an autoimmune one — and underwriters evaluate it differently from osteoarthritis and inflammatory arthritis. The primary concerns in gout underwriting are uric acid control (whether it is managed to a target level with urate-lowering therapy), the frequency of acute attacks, kidney function (because hyperuricemia can damage kidneys over time), and the presence of tophi (uric acid deposits indicating chronic severe gout). Mild, infrequent gout attacks in a person with well-controlled uric acid, normal kidney function, and no tophi can underwrite at or near standard rates with many carriers. Gout that is frequent, poorly controlled, associated with renal impairment, or that has caused significant joint damage takes on a more complex underwriting profile. Gout is also frequently associated with other conditions that matter to underwriters independently: high blood pressure, elevated triglycerides, obesity, and sleep apnea. See our resources on life insurance with sleep apnea and life insurance for CPAP users for how these common gout comorbidities are handled when they appear in the same application.

The Arthritis-Depression Connection in Life Insurance Underwriting

Depression is one of the most common comorbidities in people living with chronic arthritis — particularly in RA and psoriatic arthritis — and it is a factor that underwriters evaluate as part of the complete health picture. Chronic pain, functional limitation, and the unpredictability of inflammatory disease can contribute significantly to depression and anxiety. When depression is present alongside arthritis, underwriters evaluate both conditions and how they interact: whether the depression is well-managed, whether mental health treatment is consistent, and whether there has been any history of psychiatric hospitalization or serious functional impairment. A well-documented, treated, and stable depression history alongside well-controlled arthritis generally does not prevent coverage — but both conditions need to be addressed cleanly in the file. Our resource on life insurance with depression covers how mental health history is evaluated independently, which is useful background for applicants managing both conditions.

Arthritis and Disability Insurance: A Related Planning Need

Arthritis — particularly inflammatory arthritis — is one of the leading causes of disability in the workforce. Life insurance protects dependents if you die; disability insurance protects your income if you cannot work due to your condition. For people living with RA, psoriatic arthritis, or ankylosing spondylitis, both coverages warrant attention because the same condition that affects life insurance underwriting also affects disability insurance underwriting. Disability insurance for people with arthritis involves its own set of carrier-specific guidelines around occupation class, benefit amounts, and whether the policy will include an exclusion for arthritis-related claims. Some carriers will offer full disability coverage with arthritis history when the disease is well-controlled; others will attach a musculoskeletal or arthritis-related exclusion. Our disability insurance services overview and resource on disability insurance riders explained provide context on how disability coverage is structured and what riders are most relevant for chronic condition applicants.

What Underwriters Usually Want to See in Arthritis Cases

When you apply for life insurance with arthritis, carriers are trying to determine how stable and predictable your long-term health is. The strongest arthritis files show consistent treatment history, clear follow-up, and stable clinical notes demonstrating the condition is managed and not rapidly worsening. Underwriters look for routine rheumatology visits where applicable, medication adherence, and documentation that daily function remains intact. For inflammatory arthritis, lab markers like ESR and CRP can come up, but the overall pattern matters more than any single number. Red flags include repeated ER visits for arthritis flares, frequent medication changes due to poor control, major work restrictions, or systemic complications beyond joint pain. If your medical file shows you are under appropriate care, your treatment plan is working, and your condition is controlled, underwriting is typically more favorable than most applicants expect. For additional context on what the underwriting exam itself involves, see our guide to what to expect from a life insurance medical exam.

What Types of Policies Work Best for Arthritis

Most arthritis applicants start with term life insurance because it offers the most coverage for the lowest cost. For someone protecting children, a spouse, a mortgage, or a business obligation, term is often the cleanest solution. A well-structured 15-year term, 20-year term, or 30-year term policy can lock in a premium for the duration, and for many arthritis cases — especially mild OA or controlled RA — term underwriting can still result in meaningful coverage at a reasonable price. Permanent coverage plays a role especially for older applicants or those who want lifetime protection that does not expire. Some applicants with arthritis prefer permanent coverage because they do not want to re-qualify later if the condition progresses, and the conversion provision on a term policy is a valuable tool for this — it allows locking in coverage now and converting to a permanent structure later without new underwriting. Some applicants use a layered approach: a larger term policy for high-priority obligations combined with a smaller permanent policy for long-term needs. This can be effective in arthritis cases where the applicant wants long-term security at a manageable monthly cost. Our full life insurance services overview covers the complete spectrum of structures available.

Why Some People Get Overpriced Quotes — And How to Avoid It

The biggest reason arthritis applicants get overpriced quotes is straightforward: the case goes to the wrong company first. Many carriers have rigid internal guidelines for autoimmune conditions and may automatically apply higher table ratings to rheumatoid arthritis regardless of how well the file demonstrates control. Another common issue is incomplete documentation. If the carrier cannot clearly tell whether the condition is stable, they often assume worse-case risk — generating additional requirements, delays, higher offers, or declines that do not truly reflect the risk when records are clear and properly positioned. Working with an independent life insurance broker who specializes in impaired risk is typically the most important single decision an arthritis applicant can make. An independent broker can match the case to carriers known for more nuanced arthritis underwriting rather than forcing the file into one company’s underwriting box. For applicants who have already been declined, our resource on life insurance after a prior decline explains how to approach a second application strategically and avoid mistakes that compound the difficulty.

Arthritis Plus Other Conditions: The Real Underwriting Picture

Arthritis rarely exists in isolation. Many applicants also manage high cholesterol, mild hypertension, sleep apnea, asthma, diabetes, or a higher BMI. The underwriting outcome depends on how those risk factors stack together. Controlled osteoarthritis alongside well-managed blood pressure may barely move the needle. But if it comes with poorly controlled hypertension and a history of smoking, premiums rise sharply. With RA, carriers look carefully at inflammation-driven cardiovascular risk patterns alongside the arthritis history — which is why the cardiovascular event history, diabetes status, and other metabolic factors in the file are evaluated together rather than in isolation. If asthma is part of the picture, our resource on life insurance for asthma covers how that specific comorbidity is handled — and when arthritis, asthma, and other conditions appear together, the carrier matching process becomes even more important. Some IBD conditions also carry arthritis as an extraintestinal manifestation — if inflammatory bowel disease is part of your history alongside arthritis, see our resource on life insurance for colitis and Crohn’s disease for how those two conditions interact in underwriting. When arthritis is part of a broader health picture, we focus on “approval probability across the full file” rather than chasing a perfect class that the combined profile may not support.

What You Can Reasonably Expect With Arthritis Life Insurance

Most well-controlled osteoarthritis cases qualify for mainstream coverage, often at near-standard rates with the right carrier. Controlled rheumatoid and psoriatic arthritis cases may result in table ratings, but not always severe ones — and the strongest offers come when records show stable control, consistent follow-up, minimal functional limitation, and no major systemic complications. Gout cases that are well-managed with normal kidney function often underwrite close to standard. Ankylosing spondylitis cases are more variable and generally require more documentation around cardiac and pulmonary function given the long-term involvement pattern of the disease. Underwriting outcomes also improve over time — if someone applies too soon after diagnosis or during a period of medication trial-and-error, it may lead to higher offers than waiting until stability is achieved. Timing and strategy matter as much as the diagnosis itself. After coverage is secured, maintaining beneficiary designations is an important ongoing step — our annual beneficiary review checklist and resource on beneficiary designation mistakes to avoid are practical tools for keeping the plan current.